Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Longhi

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Idcases|January 22, 2016
Chikungunya fever: Atypical and lethal cases in the Western hemisphere: A Venezuelan experienceJaime R Torres, Leopoldo Códova G, Julio S Castro, et al.
Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.
Plos One|May 10, 2012
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β proteinMaximiliano Juri Ayub, Benson Nyambega, Leandro Simonetti, et al.
Acta Oncologica (Stockholm, Sweden)|May 8, 1998
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th studyG Bacci, S Ferrari, M Mercuri, et al.
Scandinavian Journal of Immunology|February 18, 2003
Effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigenK A Gómez, S A Longhi, V J Marino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideG Bacci, A Briccoli, M Rocca, et al.
The American Journal of Tropical Medicine and Hygiene|August 3, 2012
Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical formsSilvia A Longhi, Silvia B Brandariz, Sonia O Lafon, et al.
Frontiers in Cellular and Infection Microbiology|April 3, 2026
Placental transcriptome profiling in congenital Chagas disease: gene networks associated with transmissionSofia Apodaca, Emiliano E Campos, Kevin D Calupiña, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot studyG Bacci, S Ferrari, A Longhi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Idcases|January 22, 2016
Chikungunya fever: Atypical and lethal cases in the Western hemisphere: A Venezuelan experienceJaime R Torres, Leopoldo Códova G, Julio S Castro, et al.
Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.
Plos One|May 10, 2012
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β proteinMaximiliano Juri Ayub, Benson Nyambega, Leandro Simonetti, et al.
Acta Oncologica (Stockholm, Sweden)|May 8, 1998
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th studyG Bacci, S Ferrari, M Mercuri, et al.
Scandinavian Journal of Immunology|February 18, 2003
Effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigenK A Gómez, S A Longhi, V J Marino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideG Bacci, A Briccoli, M Rocca, et al.
The American Journal of Tropical Medicine and Hygiene|August 3, 2012
Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical formsSilvia A Longhi, Silvia B Brandariz, Sonia O Lafon, et al.
Frontiers in Cellular and Infection Microbiology|April 3, 2026
Placental transcriptome profiling in congenital Chagas disease: gene networks associated with transmissionSofia Apodaca, Emiliano E Campos, Kevin D Calupiña, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot studyG Bacci, S Ferrari, A Longhi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Pageof 13